SynthesisMedicine2020

The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia: A meta-analysis of randomized clinical trials.

Hanyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.